Plain-English translation of NCT06985693 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing Medipixel XA, a new artificial intelligence tool designed to help doctors optimize the placement of heart stents in patients with coronary artery disease. The AI system analyzes your heart's blood vessels before and during the stent placement procedure to help your doctor choose the right balloon and stent size. Researchers want to see if this technology can reduce complications and improve outcomes over the 12 months following your procedure.
Currently, doctors rely on standard imaging and experience to decide which stent size to use, which sometimes leads to complications like the stent closing back up or the vessel being damaged. This study exists to find out whether the new treatment can make stent placement more precise and safer for patients.
You likely qualify if…
You likely don't qualify if…
You will undergo a heart catheterization procedure where doctors use the Medipixel XA system to analyze your blocked artery and guide the placement of your stent. The procedure itself is similar to standard stent placement but with added AI-guided planning to optimize device selection. After your procedure, you will have follow-up visits and imaging at 12 months to check for any complications and assess how well your stent is working.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
South Korea